Real-Time L-Dopa Monitoring for Improved Management of Parkinson Disease
Real-Time L-Dopa Monitoring for Improved Management of Parkinson Disease
批准号:
10056836
负责人:
Irene Litvan
金额:
$43.39万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-08-01 至 2023-07-31
关键词:
AccountingAddressAwardBehavioralBloodChemicalsClinicalDataDecentralizationDetectionDevelopmentDevicesDiabetes MellitusDiseaseDisease ManagementDopamineDoseEffectivenessElectrochemistryEnsureFatigueFeedbackGoalsGoldHigh Pressure Liquid ChromatographyHourIndividualInsulin Infusion SystemsIntercellular FluidKnowledgeLeadLegal patentLevodopaMeasuresMethodsModernizationMonitorMoodsMotorMovement DisordersMulti-site clinical studyNeurologistNeurosciencesOralOutcomeParkinson DiseasePatientsPerformancePharmaceutical PreparationsPhysiciansPlasmaPublic HealthPublicationsPumpRegimenResearchResourcesSpecialistSurfaceSymptomsSystemTechnologyTimeTreatment Efficacybasedesigndiabetes managementdrug testingexperienceglucose monitorhigh standardillness lengthimprovedinnovationinsightmeterminimally invasivemultidisciplinarymultimodalitynon-motor symptomnovelprecision medicinereal time monitoringresponsesensorsymptom managementwearable sensor technology
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
The administration of L-Dopa therapies is highly individualized and must be dosed in accordance with the
control of symptoms, which vary among individuals; hence, there is no “standard dose” of L-Dopa. The
long-term goal of this project is to develop a wearable microneedle sensor for continuous real-time
monitoring of L-Dopa toward identifying the proper L-Dopa dosing regimen and improving the
management of Parkinson's disease. Such continuous L-Dopa monitoring capability would constitute a
paradigm shift by allowing PD patients and physicians to better manage the disease. As with a closed-
loop glucose monitor-insulin pump system, the insight gathered from this research could lead towards
the development of a metered L-Dopa pump, ensuring accurate L-Dopa administration by accounting for
circulating blood levels of L-Dopa. The proposed research is significant because of its potential to
improve public health through improved understanding of symptom fluctuations at different disease
stages and its contribution to scientific knowledge about how to improve the disease management.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
[18F]PI-2620 Binding Patterns in Patients with Suspected Alzheimer Disease and Frontotemporal Lobar Degeneration.
[18F]PI-2620 在疑似阿尔茨海默病和额颞叶变性患者中的结合模式。
DOI:
10.2967/jnumed.123.265856
发表时间:
2023
期刊:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
影响因子:
--
作者:
[Blazhenets,Ganna, Soleimani-Meigooni,DavidN, Thomas,Wesley, Mundada,Nidhi, Brendel,Matthias, Vento,Stephanie, VandeVrede,Lawren, Heuer,HilaryW, Ljubenkov,Peter, Rojas,JulioC, Chen,MirandaK, Amuiri,AlindaN, Miller,Zachary, Gorno-Tempini,]
通讯作者:
Gorno-Tempini,
DOI:
10.1016/j.cortex.2021.03.006
发表时间:
2021-06
期刊:
Cortex; a journal devoted to the study of the nervous system and behavior
影响因子:
--
作者:
[Barker MS, Manoochehri M, Rizer SJ, Appleby BS, Brushaber D, Dev SI, Devick KL, Dickerson BC, Fields JA, Foroud TM, Forsberg LK, Galasko DR, Ghoshal N, Graff-Radford NR, Grossman M, Heuer HW, Hsiung GY, Kornak J, Litvan I, Mackenzie IR, Mendez MF, Pascual B, Rankin KP, Rascovsky K, Staffaroni AM, Tartaglia MC, Weintraub S, Wong B, Boeve BF, Boxer AL, Rosen HJ, Goldman J, Huey ED, Cosentino S, ALLFTD consortium]
通讯作者:
ALLFTD consortium
DOI:
10.1136/jnnp-2020-325668
发表时间:
2021-07
期刊:
Journal of neurology, neurosurgery, and psychiatry
影响因子:
--
作者:
[Bayram E, Coughlin DG, Banks SJ, Litvan I]
通讯作者:
Litvan I
DOI:
10.1002/anie.202106674
发表时间:
2021-08-23
期刊:
Angewandte Chemie (International ed. in English)
影响因子:
--
作者:
[Moon JM, Teymourian H, De la Paz E, Sempionatto JR, Mahato K, Sonsa-Ard T, Huang N, Longardner K, Litvan I, Wang J]
通讯作者:
Wang J
Why Therapeutic Trials Fail in Primary Tauopathies.
为什么原发性 Tau蛋白病的治疗试验失败。
DOI:
10.1002/mds.29322
发表时间:
2023
期刊:
Movement disorders : official journal of the Movement Disorder Society
影响因子:
--
作者:
[Olfati,Nahid, Ghodsi,Hamidreza, Bayram,Ece, Litvan,Irene]
通讯作者:
Litvan,Irene
共 9 条
Second International Brainstorming Meeting on Parkinson Disease: Nosology
-
批准号:7485398
-
项目类别:
-
资助金额:$1.25万
-
财政年份:2008
-
负责人:Irene Litvan
-
依托单位:
Genetic and Environmental Risk Factors for PSP
-
批准号:7096316
-
项目类别:
-
资助金额:$62.89万
-
财政年份:2006
-
负责人:Irene Litvan
-
依托单位:
Genetic and Environmental Risk Factors for PSP
-
批准号:7870302
-
项目类别:
-
资助金额:$43.37万
-
财政年份:2006
-
负责人:Irene Litvan
-
依托单位:
Genetic and Environmental Risk Factors for PSP
-
批准号:7631302
-
项目类别:
-
资助金额:$55.06万
-
财政年份:2006
-
负责人:Irene Litvan
-
依托单位:
Genetic and Environmental Risk Factors for PSP
-
批准号:7457789
-
项目类别:
-
资助金额:$54.31万
-
财政年份:2006
-
负责人:Irene Litvan
-
依托单位:
Genetic and Environmental Risk Factors for PSP
-
批准号:7259458
-
项目类别:
-
资助金额:$56.71万
-
财政年份:2006
-
负责人:Irene Litvan
-
依托单位:
海外基金